| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 976 | 22 | 1148 | 104 | 1266 | 208 | 1266 |
| ERLYTX | 96 | 1 | 52 | 5 | 61 | 13 | 79 |
| GI | 192 | 2 | 104 | 13 | 158 | 33 | 201 |
| GU | 442 | 9 | 470 | 36 | 438 | 65 | 396 |
| LEUK | 137 | 2 | 104 | 9 | 110 | 23 | 140 |
| LUNG | 235 | 4 | 209 | 19 | 231 | 28 | 170 |
| LYMPH | 385 | 6 | 313 | 27 | 329 | 60 | 365 |
| MELAN | 302 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 178 | 0 | 0 | 5 | 61 | 17 | 103 |
| MULT | 15 | 0 | 0 | 5 | 61 | 11 | 67 |
| OTHER | 40 | 0 | 0 | 4 | 49 | 9 | 55 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3005 | 46 | 2400 | 228 | 2776 | 469 | 2854 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 1 | 1 | 52 | 1 | 12 | 1 | 6 | |
| CCD | 120 | 3 | 157 | 16 | 195 | 25 | 152 |
| ERLYTX | 10 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 673 | 7 | 365 | 52 | 633 | 102 | 621 |
| LUNG | 289 | 9 | 470 | 33 | 402 | 75 | 457 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 34 | 1 | 52 | 6 | 73 | 9 | 55 |
| PEOLC | 116 | 4 | 209 | 17 | 207 | 36 | 219 |
| PREV | 235 | 5 | 261 | 20 | 244 | 37 | 225 |
| SURV | 17 | 1 | 52 | 2 | 24 | 7 | 43 |
| SXQOL | 586 | 12 | 626 | 53 | 645 | 97 | 590 |
| Total | 2082 | 43 | 2244 | 201 | 2447 | 390 | 2374 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 3 | 1 | 52 | 1 | 12 | 2 | 12 | |
| BREAST | 976 | 22 | 1148 | 104 | 1266 | 208 | 1266 |
| CCD | 120 | 3 | 157 | 16 | 195 | 25 | 152 |
| ERLYTX | 106 | 1 | 52 | 6 | 73 | 14 | 85 |
| GI | 192 | 2 | 104 | 13 | 158 | 33 | 201 |
| GU | 442 | 9 | 470 | 36 | 438 | 65 | 396 |
| LEUK | 810 | 9 | 470 | 61 | 743 | 125 | 761 |
| LUNG | 524 | 13 | 678 | 52 | 633 | 103 | 627 |
| LYMPH | 386 | 6 | 313 | 27 | 329 | 60 | 365 |
| MELAN | 302 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 178 | 0 | 0 | 5 | 61 | 17 | 103 |
| MULT | 15 | 0 | 0 | 5 | 61 | 11 | 67 |
| OTHER | 74 | 1 | 52 | 10 | 122 | 18 | 110 |
| PEOLC | 116 | 4 | 209 | 17 | 207 | 36 | 219 |
| PREV | 238 | 5 | 261 | 20 | 244 | 37 | 225 |
| SURV | 17 | 1 | 52 | 2 | 24 | 7 | 43 |
| SXQOL | 588 | 12 | 626 | 53 | 645 | 97 | 590 |
| Total | 5087 | 89 | 4644 | 429 | 5223 | 859 | 5228 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 598 | 16 | 835 | 66 | 804 | 132 | 804 |
| ERLYTX | 53 | 0 | 0 | 2 | 24 | 8 | 49 |
| GI | 141 | 2 | 104 | 11 | 134 | 22 | 134 |
| GU | 373 | 6 | 313 | 26 | 317 | 47 | 286 |
| LEUK | 83 | 2 | 104 | 5 | 61 | 11 | 67 |
| LUNG | 152 | 2 | 104 | 9 | 110 | 15 | 91 |
| LYMPH | 242 | 4 | 209 | 15 | 183 | 34 | 207 |
| MELAN | 192 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 112 | 0 | 0 | 3 | 37 | 8 | 49 |
| MULT | 6 | 0 | 0 | 2 | 24 | 4 | 24 |
| OTHER | 40 | 0 | 0 | 4 | 49 | 9 | 55 |
| PREV | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1999 | 32 | 1669 | 144 | 1755 | 292 | 1778 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 105 | 3 | 157 | 14 | 170 | 21 | 128 |
| ERLYTX | 10 | 0 | 0 | 1 | 12 | 1 | 6 |
| LEUK | 315 | 7 | 365 | 30 | 365 | 50 | 304 |
| LUNG | 177 | 6 | 313 | 21 | 256 | 47 | 286 |
| LYMPH | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| OTHER | 34 | 1 | 52 | 6 | 73 | 9 | 55 |
| PEOLC | 81 | 3 | 157 | 13 | 158 | 27 | 164 |
| PREV | 235 | 5 | 261 | 20 | 244 | 37 | 225 |
| SURV | 16 | 0 | 0 | 1 | 12 | 6 | 37 |
| SXQOL | 393 | 5 | 261 | 29 | 353 | 61 | 371 |
| Total | 1367 | 30 | 1566 | 135 | 1643 | 259 | 1576 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 1 | 6 | |
| BREAST | 792 | 21 | 1096 | 90 | 1096 | 169 | 1029 |
| CCD | 139 | 3 | 157 | 16 | 195 | 33 | 201 |
| ERLYTX | 63 | 0 | 0 | 3 | 37 | 9 | 55 |
| GI | 148 | 3 | 157 | 12 | 146 | 26 | 158 |
| GU | 393 | 7 | 365 | 29 | 353 | 52 | 317 |
| LEUK | 398 | 9 | 470 | 35 | 426 | 61 | 371 |
| LUNG | 330 | 8 | 417 | 30 | 365 | 62 | 377 |
| LYMPH | 243 | 4 | 209 | 15 | 183 | 34 | 207 |
| MELAN | 192 | 0 | 0 | 1 | 12 | 1 | 6 |
| MMYEL | 107 | 0 | 0 | 3 | 37 | 8 | 49 |
| MULT | 21 | 1 | 52 | 5 | 61 | 8 | 49 |
| OTHER | 245 | 2 | 104 | 21 | 256 | 47 | 286 |
| PEOLC | 90 | 4 | 209 | 14 | 170 | 28 | 170 |
| PREV | 238 | 5 | 261 | 20 | 244 | 37 | 225 |
| SURV | 16 | 0 | 0 | 1 | 12 | 6 | 37 |
| SXQOL | 395 | 5 | 261 | 29 | 353 | 61 | 371 |
| Total | 3812 | 72 | 3758 | 324 | 3946 | 643 | 3914 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 830 | 20 | 1044 | 84 | 1023 | 164 | 998 |
| ERLYTX | 92 | 1 | 52 | 5 | 61 | 11 | 67 |
| GI | 107 | 1 | 52 | 7 | 85 | 22 | 134 |
| GU | 247 | 7 | 365 | 23 | 280 | 44 | 268 |
| LEUK | 107 | 2 | 104 | 8 | 97 | 20 | 122 |
| LUNG | 205 | 4 | 209 | 17 | 207 | 25 | 152 |
| LYMPH | 314 | 3 | 157 | 23 | 280 | 50 | 304 |
| MMYEL | 165 | 0 | 0 | 4 | 49 | 15 | 91 |
| MULT | 15 | 0 | 0 | 5 | 61 | 11 | 67 |
| Total | 2082 | 38 | 1983 | 176 | 2143 | 362 | 2203 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1973 | 39 | 2035 | 168 | 2045 | 329 | 2003 |
| AFFIL | 125 | 3 | 157 | 13 | 158 | 24 | 146 |
| CCOP/NCORP | 1268 | 20 | 1044 | 98 | 1193 | 198 | 1205 |
| Non-SWOG | 1718 | 24 | 1252 | 147 | 1790 | 305 | 1857 |
| Total | 5084 | 86 | 4488 | 426 | 5186 | 856 | 5211 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| MMYEL | S2005 | WM, Prev. Untreated, I/R +/- Venetoclax | 1 | T | 20-NOV-25 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 13 |
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 13 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 9 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 7 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 7 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 7 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 2 | 4 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 3 |
| LYMPH | AHOD2131 | cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy | 1 | 3 |
| LUNG | S1800E | Non-Match: Docetaxel + Ramu +/- Cemiplimab | 1 | 3 |
| GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 3 |
| MULT | S2101 | Melan or HNSCC, Adv, Cabo + Nivo | 1 | 3 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | 3 |